Hologic, Inc. (HOLX)
USD 58.46
(-4.59%)
USD 58.46
(-4.59%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 2.22 Billion USD | 7.55% |
| 2023 | 2.07 Billion USD | -30.89% |
| 2022 | 2.99 Billion USD | -21.03% |
| 2021 | 3.79 Billion USD | 70.41% |
| 2020 | 2.22 Billion USD | 70.29% |
| 2019 | 1.3 Billion USD | -22.9% |
| 2018 | 1.69 Billion USD | 4.67% |
| 2017 | 1.62 Billion USD | 3.69% |
| 2016 | 1.56 Billion USD | 9.12% |
| 2015 | 1.43 Billion USD | 15.03% |
| 2014 | 1.24 Billion USD | 7.24% |
| 2013 | 1.16 Billion USD | 16.79% |
| 2012 | 994.43 Million USD | 7.72% |
| 2011 | 923.18 Million USD | 25.32% |
| 2010 | 736.63 Million USD | -14.09% |
| 2009 | 857.48 Million USD | -3.93% |
| 2008 | 892.51 Million USD | 158.28% |
| 2007 | 345.56 Million USD | 78.56% |
| 2006 | 193.53 Million USD | 71.23% |
| 2005 | 113.02 Million USD | 32.4% |
| 2004 | 85.36 Million USD | 16.02% |
| 2003 | 73.58 Million USD | 2.46% |
| 2002 | 71.81 Million USD | 15.25% |
| 2001 | 62.31 Million USD | 80.3% |
| 2000 | 34.56 Million USD | -7.34% |
| 1999 | 37.3 Million USD | -39.45% |
| 1998 | 61.6 Million USD | 1.82% |
| 1997 | 60.5 Million USD | 26.57% |
| 1996 | 47.8 Million USD | 118.26% |
| 1995 | 21.9 Million USD | 20.33% |
| 1994 | 18.2 Million USD | 58.26% |
| 1993 | 11.5 Million USD | -11.54% |
| 1992 | 13 Million USD | 46.07% |
| 1991 | 8.9 Million USD | -16.04% |
| 1990 | 10.6 Million USD | 45.21% |
| 1989 | 7.3 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 557.7 Million USD | -1.88% |
| 2024 Q2 | 562.5 Million USD | -0.88% |
| 2024 Q3 | 568.3 Million USD | 1.03% |
| 2024 Q1 | 567.5 Million USD | 13.43% |
| 2023 Q2 | 585.8 Million USD | -5.2% |
| 2023 Q4 | 500.3 Million USD | 36.14% |
| 2023 Q3 | 367.5 Million USD | -37.27% |
| 2023 FY | 2.07 Billion USD | -30.89% |
| 2023 Q1 | 617.9 Million USD | 20.05% |
| 2022 Q4 | 514.7 Million USD | -6.38% |
| 2022 Q3 | 549.8 Million USD | -41.92% |
| 2022 Q1 | 986.3 Million USD | 19.1% |
| 2022 FY | 2.99 Billion USD | -21.03% |
| 2022 Q2 | 946.6 Million USD | -4.03% |
| 2021 FY | 3.79 Billion USD | 70.41% |
| 2021 Q1 | 1.18 Billion USD | 26.68% |
| 2021 Q2 | 1.08 Billion USD | -8.01% |
| 2021 Q3 | 701.6 Million USD | -35.38% |
| 2021 Q4 | 828.1 Million USD | 18.03% |
| 2020 Q4 | 931.8 Million USD | 99.91% |
| 2020 Q3 | 466.1 Million USD | 17.76% |
| 2020 Q2 | 395.8 Million USD | -8.76% |
| 2020 FY | 2.22 Billion USD | 70.29% |
| 2020 Q1 | 433.8 Million USD | 12.18% |
| 2019 FY | 1.3 Billion USD | -22.9% |
| 2019 Q1 | 434.1 Million USD | 3.09% |
| 2019 Q2 | 42.4 Million USD | -90.23% |
| 2019 Q3 | 444.8 Million USD | 949.06% |
| 2019 Q4 | 386.7 Million USD | -13.06% |
| 2018 Q3 | 436 Million USD | 5.03% |
| 2018 Q2 | 415.1 Million USD | -2.21% |
| 2018 Q1 | 424.5 Million USD | 1.58% |
| 2018 FY | 1.69 Billion USD | 4.67% |
| 2018 Q4 | 421.1 Million USD | -3.42% |
| 2017 Q2 | 388.7 Million USD | -3.98% |
| 2017 Q3 | 409.6 Million USD | 5.38% |
| 2017 Q4 | 417.9 Million USD | 2.03% |
| 2017 Q1 | 404.8 Million USD | -0.32% |
| 2017 FY | 1.62 Billion USD | 3.69% |
| 2016 Q4 | 406.1 Million USD | 3.31% |
| 2016 Q1 | 379.1 Million USD | -0.08% |
| 2016 FY | 1.56 Billion USD | 9.12% |
| 2016 Q3 | 393.1 Million USD | 2.1% |
| 2016 Q2 | 385 Million USD | 1.56% |
| 2015 Q3 | 378.7 Million USD | 12.71% |
| 2015 Q2 | 336 Million USD | -0.77% |
| 2015 Q1 | 338.6 Million USD | -1.86% |
| 2015 FY | 1.43 Billion USD | 15.03% |
| 2015 Q4 | 379.4 Million USD | 0.18% |
| 2014 Q3 | 312.8 Million USD | 10.88% |
| 2014 Q4 | 345 Million USD | 10.29% |
| 2014 FY | 1.24 Billion USD | 7.24% |
| 2014 Q1 | 305.59 Million USD | 5.15% |
| 2014 Q2 | 282.11 Million USD | -7.68% |
| 2013 FY | 1.16 Billion USD | 16.79% |
| 2013 Q4 | 290.63 Million USD | -6.17% |
| 2013 Q3 | 309.75 Million USD | 10.89% |
| 2013 Q2 | 279.32 Million USD | -0.83% |
| 2013 Q1 | 281.67 Million USD | 2.68% |
| 2012 FY | 994.43 Million USD | 7.72% |
| 2012 Q1 | 249.37 Million USD | 2.3% |
| 2012 Q3 | 244.64 Million USD | 8.2% |
| 2012 Q4 | 274.31 Million USD | 12.13% |
| 2012 Q2 | 226.11 Million USD | -9.33% |
| 2011 Q3 | 234.28 Million USD | 6.29% |
| 2011 Q1 | 224.73 Million USD | 132.49% |
| 2011 Q2 | 220.4 Million USD | -1.92% |
| 2011 FY | 923.18 Million USD | 25.32% |
| 2011 Q4 | 243.75 Million USD | 4.04% |
| 2010 Q2 | 213.63 Million USD | -1.3% |
| 2010 FY | 736.63 Million USD | -14.09% |
| 2010 Q3 | 209.88 Million USD | -1.76% |
| 2010 Q4 | 96.66 Million USD | -53.94% |
| 2010 Q1 | 216.44 Million USD | 4.66% |
| 2009 Q2 | 210.26 Million USD | -8.85% |
| 2009 Q1 | 230.66 Million USD | -4.0% |
| 2009 Q3 | 211.14 Million USD | 0.42% |
| 2009 Q4 | 206.8 Million USD | -2.05% |
| 2009 FY | 857.48 Million USD | -3.93% |
| 2008 Q2 | 239.63 Million USD | 42.78% |
| 2008 Q4 | 240.28 Million USD | -1.83% |
| 2008 Q3 | 244.76 Million USD | 2.14% |
| 2008 Q1 | 167.83 Million USD | 72.05% |
| 2008 FY | 892.51 Million USD | 158.28% |
| 2007 FY | 345.56 Million USD | 78.56% |
| 2007 Q1 | 74.35 Million USD | 17.95% |
| 2007 Q2 | 83.54 Million USD | 12.36% |
| 2007 Q3 | 90.11 Million USD | 7.86% |
| 2007 Q4 | 97.54 Million USD | 8.25% |
| 2006 Q1 | 36.98 Million USD | 15.74% |
| 2006 Q4 | 63.04 Million USD | 25.11% |
| 2006 Q3 | 50.38 Million USD | 16.85% |
| 2006 Q2 | 43.12 Million USD | 16.6% |
| 2006 FY | 193.53 Million USD | 71.23% |
| 2005 Q2 | 26.77 Million USD | 10.6% |
| 2005 Q3 | 30.09 Million USD | 12.39% |
| 2005 Q4 | 31.95 Million USD | 6.19% |
| 2005 FY | 113.02 Million USD | 32.4% |
| 2005 Q1 | 24.2 Million USD | 4.48% |
| 2004 Q3 | 22.18 Million USD | 7.75% |
| 2004 Q2 | 20.59 Million USD | 6.02% |
| 2004 Q4 | 23.16 Million USD | 4.43% |
| 2004 Q1 | 19.42 Million USD | 2.57% |
| 2004 FY | 85.36 Million USD | 16.02% |
| 2003 FY | 73.58 Million USD | 2.46% |
| 2003 Q4 | 18.93 Million USD | 2.15% |
| 2003 Q2 | 18.35 Million USD | 3.34% |
| 2003 Q3 | 18.53 Million USD | 1.02% |
| 2003 Q1 | 17.75 Million USD | -1.2% |
| 2002 Q4 | 17.97 Million USD | -0.97% |
| 2002 Q2 | 18.02 Million USD | 2.03% |
| 2002 Q1 | 17.66 Million USD | 10.94% |
| 2002 FY | 71.81 Million USD | 15.25% |
| 2002 Q3 | 18.14 Million USD | 0.67% |
| 2001 Q3 | 18.64 Million USD | 10.16% |
| 2001 Q4 | 15.92 Million USD | -14.6% |
| 2001 FY | 62.31 Million USD | 80.3% |
| 2001 Q2 | 16.92 Million USD | 9.46% |
| 2001 Q1 | 15.46 Million USD | 188.9% |
| 2000 Q1 | 9.1 Million USD | 19.74% |
| 2000 FY | 34.56 Million USD | -7.34% |
| 2000 Q2 | 10.52 Million USD | 15.69% |
| 2000 Q3 | 9.28 Million USD | -11.82% |
| 2000 Q4 | 5.35 Million USD | -42.34% |
| 1999 Q2 | 8.1 Million USD | -29.57% |
| 1999 FY | 37.3 Million USD | -39.45% |
| 1999 Q1 | 11.5 Million USD | -25.32% |
| 1999 Q4 | 7.6 Million USD | -13.64% |
| 1999 Q3 | 8.8 Million USD | 8.64% |
| 1998 FY | 61.6 Million USD | 1.82% |
| 1998 Q2 | 15.9 Million USD | 16.06% |
| 1998 Q3 | 18.2 Million USD | 14.47% |
| 1998 Q4 | 15.4 Million USD | -15.38% |
| 1998 Q1 | 13.7 Million USD | -0.72% |
| 1997 Q2 | 15.9 Million USD | 3.25% |
| 1997 Q4 | 13.8 Million USD | -9.8% |
| 1997 Q3 | 15.3 Million USD | -3.77% |
| 1997 FY | 60.5 Million USD | 26.57% |
| 1997 Q1 | 15.4 Million USD | -4.35% |
| 1996 Q2 | 10.5 Million USD | 28.05% |
| 1996 Q4 | 16.1 Million USD | 22.9% |
| 1996 Q3 | 13.1 Million USD | 24.76% |
| 1996 Q1 | 8.2 Million USD | 18.84% |
| 1996 FY | 47.8 Million USD | 118.26% |
| 1995 Q2 | 4.3 Million USD | -14.0% |
| 1995 Q3 | 5.7 Million USD | 32.56% |
| 1995 Q1 | 5 Million USD | 8.7% |
| 1995 Q4 | 6.9 Million USD | 21.05% |
| 1995 FY | 21.9 Million USD | 20.33% |
| 1994 Q2 | 4.7 Million USD | 30.56% |
| 1994 Q1 | 3.6 Million USD | 28.57% |
| 1994 FY | 18.2 Million USD | 58.26% |
| 1994 Q4 | 4.6 Million USD | -9.8% |
| 1994 Q3 | 5.1 Million USD | 8.51% |
| 1993 Q2 | 2.8 Million USD | -48.15% |
| 1993 FY | 11.5 Million USD | -11.54% |
| 1993 Q4 | 2.8 Million USD | -9.68% |
| 1993 Q1 | 5.4 Million USD | 58.82% |
| 1993 Q3 | 3.1 Million USD | 10.71% |
| 1992 FY | 13 Million USD | 46.07% |
| 1992 Q4 | 3.4 Million USD | -5.56% |
| 1992 Q1 | 2.7 Million USD | -40.0% |
| 1992 Q2 | 3.2 Million USD | 18.52% |
| 1992 Q3 | 3.6 Million USD | 12.5% |
| 1991 Q1 | 3.9 Million USD | -18.75% |
| 1991 Q2 | 4.2 Million USD | 7.69% |
| 1991 Q3 | 4.5 Million USD | 7.14% |
| 1991 Q4 | 4.5 Million USD | 0.0% |
| 1991 FY | 8.9 Million USD | -16.04% |
| 1990 FY | 10.6 Million USD | 45.21% |
| 1990 Q1 | 3.9 Million USD | 14.71% |
| 1990 Q4 | 4.8 Million USD | -20.0% |
| 1990 Q3 | 6 Million USD | 160.87% |
| 1990 Q2 | 2.3 Million USD | -41.03% |
| 1989 Q2 | 2.6 Million USD | 18.18% |
| 1989 Q3 | 3.2 Million USD | 23.08% |
| 1989 Q4 | 3.4 Million USD | 6.25% |
| 1989 FY | 7.3 Million USD | 0.0% |
| 1989 Q1 | 2.2 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -3856.665% |
| AngioDynamics, Inc. | 154.69 Million USD | -1340.096% |
| AtriCure, Inc. | 300.37 Million USD | -641.685% |
| Avinger, Inc. | 2 Million USD | -111123.165% |
| Azenta, Inc. | 263.14 Million USD | -746.622% |
| BioLife Solutions, Inc. | 46.75 Million USD | -4665.144% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 5.518% |
| Daxor Corporation | 1.1 Million USD | -201795.889% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -24437.945% |
| Femasys Inc. | 691.9 Thousand USD | -321882.48% |
| GlucoTrack, Inc. | -13 Thousand USD | 17137023.077% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -3560.172% |
| ICU Medical, Inc. | 739.87 Million USD | -201.106% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 52.896% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -13233.507% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -1653.497% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1867039.302% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1867039.302% |
| Masimo Corporation | 1 Billion USD | -122.003% |
| Microbot Medical Inc. | -106 Thousand USD | 2101798.113% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -6631.53% |
| Merit Medical Systems, Inc. | 583.87 Million USD | -281.556% |
| Nephros, Inc. | 8.4 Million USD | -26405.651% |
| NovoCure Limited | 381.05 Million USD | -484.635% |
| NEXGEL, Inc. | 619 Thousand USD | -359803.069% |
| NEXGEL, Inc. | 619 Thousand USD | -359803.069% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 399347.312% |
| OraSure Technologies, Inc. | 179.42 Million USD | -1141.661% |
| Pro-Dex, Inc. | 14.55 Million USD | -15210.288% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 184673.322% |
| Predictive Oncology Inc. | 1.14 Million USD | -194417.23% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -38325.072% |
| QuidelOrtho Corporation | 1.49 Billion USD | -49.077% |
| Repligen Corporation | 315.22 Million USD | -606.727% |
| Sanara MedTech Inc. | 57.13 Million USD | -3799.039% |
| STAAR Surgical Company | 252.65 Million USD | -781.77% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 250064.095% |
| Utah Medical Products, Inc. | 30.03 Million USD | -7316.606% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | -6.798% |
| Jin Medical International Ltd. | 6.78 Million USD | -32734.996% |